| PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients Y Nagata, KH Lan, X Zhou, M Tan, FJ Esteva, AA Sahin, KS Klos, P Li, ... Cancer cell 6 (2), 117-127, 2004 | 2244 | 2004 |
| Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition BP Zhou, J Deng, W Xia, J Xu, YM Li, M Gunduz, MC Hung Nature cell biology 6 (10), 931-940, 2004 | 1876 | 2004 |
| Requirement for neuregulin receptor erbB2 in neural and cardiac development KF Lee, H Simon, H Chen, B Bates, MC Hung, C Hauser Nature 378 (6555), 394-398, 1995 | 1606 | 1995 |
| The neu oncogene encodes an epidermal growth factor receptor-related protein CI Bargmann, MC Hung, RA Weinberg Nature 319 (6050), 226-230, 1986 | 1600 | 1986 |
| Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells BP Zhou, Y Liao, W Xia, B Spohn, MH Lee, MC Hung Nature cell biology 3 (3), 245-252, 2001 | 1400 | 2001 |
| Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185 CI Bargmann, MC Hung, RA Weinberg Cell 45 (5), 649-657, 1986 | 1369 | 1986 |
| Nuclear localization of EGF receptor and its potential new role as a transcription factor SY Lin, K Makino, W Xia, A Matin, Y Wen, KY Kwong, L Bourguignon, ... Nature cell biology 3 (9), 802-808, 2001 | 1331 | 2001 |
| Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer R Nahta, D Yu, MC Hung, GN Hortobagyi, FJ Esteva Nature clinical practice Oncology 3 (5), 269-280, 2006 | 1190 | 2006 |
| An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer K Stemke-Hale, AM Gonzalez-Angulo, A Lluch, RM Neve, WL Kuo, ... Cancer research 68 (15), 6084-6091, 2008 | 1189 | 2008 |
| HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation BP Zhou, Y Liao, W Xia, Y Zou, B Spohn, MC Hung Nature cell biology 3 (11), 973-982, 2001 | 1183 | 2001 |
| Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in … AM Petit, J Rak, MC Hung, P Rockwell, N Goldstein, B Fendly, RS Kerbel The American journal of pathology 151 (6), 1523, 1997 | 1144 | 1997 |
| Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer S Jiralerspong, SL Palla, SH Giordano, F Meric-Bernstam, C Liedtke, ... Journal of clinical oncology 27 (20), 3297, 2009 | 1101 | 2009 |
| IκB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a MCT Hu, DF Lee, W Xia, LS Golfman, F Ou-Yang, JY Yang, Y Zou, S Bao, ... Cell 117 (2), 225-237, 2004 | 1082 | 2004 |
| β-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression SY Lin, W Xia, JC Wang, KY Kwong, B Spohn, Y Wen, RG Pestell, ... Proceedings of the National Academy of Sciences 97 (8), 4262-4266, 2000 | 1042 | 2000 |
| The expression patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by immunohistochemical analysis in breast cancer cell lines K Subik, JF Lee, L Baxter, T Strzepek, D Costello, P Crowley, L Xing, ... Breast cancer: basic and clinical research 4, 117822341000400004, 2010 | 1030 | 2010 |
| Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity CW Li, SO Lim, W Xia, HH Lee, LC Chan, CW Kuo, KH Khoo, SS Chang, ... Nature communications 7 (1), 12632, 2016 | 876 | 2016 |
| p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs CJ Chang, CH Chao, W Xia, JY Yang, Y Xiong, CW Li, WH Yu, ... Nature cell biology 13 (3), 317-323, 2011 | 876 | 2011 |
| PARP inhibitor upregulates PD-L1 expression and enhances cancer-associated immunosuppression S Jiao, W Xia, H Yamaguchi, Y Wei, MK Chen, JM Hsu, JL Hsu, WH Yu, ... Clinical Cancer Research 23 (14), 3711-3720, 2017 | 843 | 2017 |
| IKKβ suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway DF Lee, HP Kuo, CT Chen, JM Hsu, CK Chou, Y Wei, HL Sun, LY Li, ... Cell 130 (3), 440-455, 2007 | 812 | 2007 |
| Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer C Dong, T Yuan, Y Wu, Y Wang, TWM Fan, S Miriyala, Y Lin, J Yao, J Shi, ... Cancer cell 23 (3), 316-331, 2013 | 802 | 2013 |
